357 related articles for article (PubMed ID: 22342710)
1. Cancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticles.
Wang X; Wei F; Liu A; Wang L; Wang JC; Ren L; Liu W; Tu Q; Li L; Wang J
Biomaterials; 2012 May; 33(14):3719-32. PubMed ID: 22342710
[TBL] [Abstract][Full Text] [Related]
2. Effects of poly(L-lysine)-modified Fe3O4 nanoparticles on endogenous reactive oxygen species in cancer stem cells.
Wang X; Tu Q; Zhao B; An Y; Wang JC; Liu W; Yuan MS; Ahmed SM; Xu J; Liu R; Zhang Y; Wang J
Biomaterials; 2013 Jan; 34(4):1155-69. PubMed ID: 23164425
[TBL] [Abstract][Full Text] [Related]
3. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
[TBL] [Abstract][Full Text] [Related]
5. In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles.
Sun JH; Zhang YL; Nie CH; Qian SP; Yu XB; Xie HY; Zhou L; Zheng SS
Mol Med Rep; 2012 Aug; 6(2):282-6. PubMed ID: 22580964
[TBL] [Abstract][Full Text] [Related]
6. Cell surface Nestin is a biomarker for glioma stem cells.
Jin X; Jin X; Jung JE; Beck S; Kim H
Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties.
Hong X; Chedid K; Kalkanis SN
Int J Oncol; 2012 Nov; 41(5):1693-700. PubMed ID: 22922964
[TBL] [Abstract][Full Text] [Related]
8. Detection of cancer stem cells from the C6 glioma cell line.
Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
[TBL] [Abstract][Full Text] [Related]
9. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of umbilical cord mesenchymal stem cell labeling with superparamagnetic iron oxide nanoparticles coated with dextran and complexed with Poly-L-lysine.
Sibov TT; Miyaki LA; Mamani JB; Marti LC; Sardinha LR; Pavon LF; Oliveira DM; Cardenas WH; Gamarra LF
Einstein (Sao Paulo); 2012; 10(2):180-8. PubMed ID: 23052453
[TBL] [Abstract][Full Text] [Related]
11. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
12. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
13. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
[TBL] [Abstract][Full Text] [Related]
14. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles.
Mai XL; Ma ZL; Sun JH; Ju SH; Ma M; Teng GJ
Cell Transplant; 2009; 18(2):171-81. PubMed ID: 19499705
[TBL] [Abstract][Full Text] [Related]
15. Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells.
Chang YK; Liu YP; Ho JH; Hsu SC; Lee OK
J Orthop Res; 2012 Sep; 30(9):1499-506. PubMed ID: 22337660
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
Salmaggi A; Boiardi A; Gelati M; Russo A; Calatozzolo C; Ciusani E; Sciacca FL; Ottolina A; Parati EA; La Porta C; Alessandri G; Marras C; Croci D; De Rossi M
Glia; 2006 Dec; 54(8):850-60. PubMed ID: 16981197
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
[TBL] [Abstract][Full Text] [Related]
18. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
19. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
Arbab AS; Bashaw LA; Miller BR; Jordan EK; Lewis BK; Kalish H; Frank JA
Radiology; 2003 Dec; 229(3):838-46. PubMed ID: 14657318
[TBL] [Abstract][Full Text] [Related]
20. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
